Henry Schein, Inc. (0L3C.L)
USD 65.14
(1.15%)
USD 65.14
(1.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.57 Billion USD | 86.23% |
| 2022 | 1.38 Billion USD | 25.6% |
| 2021 | 1.09 Billion USD | 89.03% |
| 2020 | 581.23 Million USD | -34.86% |
| 2019 | 892.25 Million USD | -52.64% |
| 2018 | 1.88 Billion USD | 26.33% |
| 2017 | 1.49 Billion USD | 28.96% |
| 2016 | 1.15 Billion USD | 56.78% |
| 2015 | 737.62 Million USD | 14.89% |
| 2014 | 642.01 Million USD | 116.48% |
| 2013 | 296.56 Million USD | -27.88% |
| 2012 | 411.19 Million USD | 39.83% |
| 2011 | 294.07 Million USD | 1.07% |
| 2010 | 290.95 Million USD | 243.12% |
| 2009 | -203.28 Million USD | -448.0% |
| 2008 | 58.41 Million USD | -72.05% |
| 2007 | 208.98 Million USD | -16.65% |
| 2006 | 250.72 Million USD | -7.18% |
| 2005 | 270.12 Million USD | -22.59% |
| 2004 | 348.93 Million USD | 252.24% |
| 2003 | 99.06 Million USD | 100.68% |
| 2002 | 49.36 Million USD | -27.46% |
| 2001 | 68.05 Million USD | -68.83% |
| 2000 | 218.33 Million USD | -35.33% |
| 1999 | 337.6 Million USD | 86.31% |
| 1998 | 181.2 Million USD | 69.82% |
| 1997 | 106.7 Million USD | 5715.79% |
| 1996 | -1.9 Million USD | -105.35% |
| 1995 | 35.5 Million USD | -37.28% |
| 1994 | 56.6 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 2.7 Billion USD | 5.51% |
| 2024 Q1 | 2.55 Billion USD | -0.43% |
| 2023 Q1 | 1.53 Billion USD | 11.09% |
| 2023 Q3 | 2.12 Billion USD | 21.55% |
| 2023 Q2 | 1.74 Billion USD | 13.83% |
| 2023 FY | 2.57 Billion USD | 86.23% |
| 2023 Q4 | 2.57 Billion USD | 21.17% |
| 2022 Q2 | 1.1 Billion USD | 0.64% |
| 2022 Q1 | 1.09 Billion USD | -0.52% |
| 2022 FY | 1.38 Billion USD | 25.6% |
| 2022 Q4 | 1.38 Billion USD | 9.09% |
| 2022 Q3 | 1.26 Billion USD | 15.0% |
| 2021 Q3 | 1 Billion USD | 6.76% |
| 2021 FY | 1.09 Billion USD | 89.03% |
| 2021 Q1 | 857.71 Million USD | 47.57% |
| 2021 Q2 | 939.44 Million USD | 9.53% |
| 2021 Q4 | 1.09 Billion USD | 9.55% |
| 2020 Q1 | 965.99 Million USD | 8.26% |
| 2020 Q2 | 1.05 Billion USD | 9.47% |
| 2020 Q3 | 862.77 Million USD | -18.41% |
| 2020 Q4 | 581.23 Million USD | -32.63% |
| 2020 FY | 581.23 Million USD | -34.86% |
| 2019 Q1 | 1.45 Billion USD | -23.03% |
| 2019 FY | 892.25 Million USD | -52.64% |
| 2019 Q2 | 1.38 Billion USD | -4.38% |
| 2019 Q3 | 1.26 Billion USD | -8.86% |
| 2019 Q4 | 892.25 Million USD | -29.4% |
| 2018 Q3 | 2.03 Billion USD | -1.35% |
| 2018 Q2 | 2.06 Billion USD | 10.5% |
| 2018 Q1 | 1.86 Billion USD | 25.36% |
| 2018 FY | 1.88 Billion USD | 26.33% |
| 2018 Q4 | 1.88 Billion USD | -7.55% |
| 2017 Q1 | 1.33 Billion USD | 15.51% |
| 2017 FY | 1.49 Billion USD | 28.96% |
| 2017 Q4 | 1.49 Billion USD | 0.99% |
| 2017 Q3 | 1.47 Billion USD | 11.23% |
| 2017 Q2 | 1.32 Billion USD | -0.61% |
| 2016 Q4 | 1.15 Billion USD | 16.53% |
| 2016 Q2 | 891.49 Million USD | -13.95% |
| 2016 Q1 | 1.03 Billion USD | 40.45% |
| 2016 FY | 1.15 Billion USD | 56.78% |
| 2016 Q3 | 992.41 Million USD | 11.32% |
| 2015 Q4 | 737.62 Million USD | -0.05% |
| 2015 FY | 737.62 Million USD | 14.89% |
| 2015 Q3 | 737.96 Million USD | 7.17% |
| 2015 Q2 | 688.59 Million USD | -10.82% |
| 2015 Q1 | 772.16 Million USD | 20.27% |
| 2014 Q2 | 666.18 Million USD | 0.54% |
| 2014 Q3 | 748.86 Million USD | 12.41% |
| 2014 Q4 | 642.01 Million USD | -14.27% |
| 2014 Q1 | 662.59 Million USD | 123.42% |
| 2014 FY | 642.01 Million USD | 116.48% |
| 2013 FY | 296.56 Million USD | -27.88% |
| 2013 Q4 | 296.56 Million USD | -12.23% |
| 2013 Q3 | 337.88 Million USD | -13.22% |
| 2013 Q2 | 389.35 Million USD | -30.72% |
| 2013 Q1 | 562.01 Million USD | 36.68% |
| 2012 Q1 | 379.27 Million USD | 28.97% |
| 2012 Q3 | 520.04 Million USD | 16.31% |
| 2012 Q2 | 447.1 Million USD | 17.88% |
| 2012 FY | 411.19 Million USD | 39.83% |
| 2012 Q4 | 411.19 Million USD | -20.93% |
| 2011 Q2 | 281.55 Million USD | -28.95% |
| 2011 FY | 294.07 Million USD | 1.07% |
| 2011 Q4 | 294.07 Million USD | -9.54% |
| 2011 Q3 | 325.08 Million USD | 15.46% |
| 2011 Q1 | 396.3 Million USD | 36.21% |
| 2010 Q2 | 227.77 Million USD | 17.94% |
| 2010 FY | 290.95 Million USD | 243.12% |
| 2010 Q1 | 193.13 Million USD | 195.0% |
| 2010 Q4 | 290.95 Million USD | -28.34% |
| 2010 Q3 | 406.02 Million USD | 78.26% |
| 2009 FY | -203.28 Million USD | -448.0% |
| 2009 Q2 | 23.62 Million USD | -77.53% |
| 2009 Q3 | -49.43 Million USD | -309.27% |
| 2009 Q4 | -203.28 Million USD | -311.25% |
| 2009 Q1 | 105.13 Million USD | 79.97% |
| 2008 FY | 58.41 Million USD | -72.05% |
| 2008 Q4 | 58.41 Million USD | -58.47% |
| 2008 Q1 | 255.54 Million USD | 22.28% |
| 2008 Q2 | 182.86 Million USD | -28.44% |
| 2008 Q3 | 140.65 Million USD | -23.08% |
| 2007 Q3 | 256.72 Million USD | -11.32% |
| 2007 FY | 208.98 Million USD | -16.65% |
| 2007 Q1 | 342.71 Million USD | 36.69% |
| 2007 Q2 | 289.48 Million USD | -15.53% |
| 2007 Q4 | 208.98 Million USD | -18.6% |
| 2006 Q4 | 250.72 Million USD | -22.52% |
| 2006 FY | 250.72 Million USD | -7.18% |
| 2006 Q3 | 323.58 Million USD | -15.1% |
| 2006 Q2 | 381.12 Million USD | 5.16% |
| 2006 Q1 | 362.42 Million USD | 34.17% |
| 2005 FY | 270.12 Million USD | -22.59% |
| 2005 Q2 | 344.5 Million USD | -16.42% |
| 2005 Q3 | 304.32 Million USD | -11.66% |
| 2005 Q4 | 270.12 Million USD | -11.24% |
| 2005 Q1 | 412.2 Million USD | 18.13% |
| 2004 Q2 | 402.68 Million USD | 88.13% |
| 2004 Q4 | 348.93 Million USD | -24.23% |
| 2004 Q3 | 460.51 Million USD | 14.36% |
| 2004 Q1 | 214.04 Million USD | 116.07% |
| 2004 FY | 348.93 Million USD | 252.24% |
| 2003 FY | 99.06 Million USD | 100.68% |
| 2003 Q4 | 99.06 Million USD | -39.36% |
| 2003 Q3 | 163.36 Million USD | 20.48% |
| 2003 Q1 | 61.68 Million USD | 24.97% |
| 2003 Q2 | 135.59 Million USD | 119.82% |
| 2002 Q2 | 116.94 Million USD | -24.93% |
| 2002 Q3 | 101.58 Million USD | -13.13% |
| 2002 Q4 | 49.36 Million USD | -51.41% |
| 2002 FY | 49.36 Million USD | -27.46% |
| 2002 Q1 | 155.79 Million USD | 128.93% |
| 2001 Q1 | 228.51 Million USD | 4.67% |
| 2001 Q4 | 68.05 Million USD | -57.5% |
| 2001 FY | 68.05 Million USD | -68.83% |
| 2001 Q3 | 160.13 Million USD | -15.12% |
| 2001 Q2 | 188.66 Million USD | -17.44% |
| 2000 Q3 | 268.53 Million USD | -3.21% |
| 2000 Q4 | 218.33 Million USD | -18.7% |
| 2000 Q1 | 332.55 Million USD | -1.49% |
| 2000 Q2 | 277.44 Million USD | -16.57% |
| 2000 FY | 218.33 Million USD | -35.33% |
| 1999 FY | 337.6 Million USD | 86.31% |
| 1999 Q4 | 337.6 Million USD | 10.25% |
| 1999 Q3 | 306.2 Million USD | -9.89% |
| 1999 Q2 | 339.8 Million USD | -4.36% |
| 1999 Q1 | 355.3 Million USD | 96.08% |
| 1998 Q1 | 131.2 Million USD | 22.96% |
| 1998 Q3 | 193.6 Million USD | 48.13% |
| 1998 Q4 | 181.2 Million USD | -6.4% |
| 1998 FY | 181.2 Million USD | 69.82% |
| 1998 Q2 | 130.7 Million USD | -0.38% |
| 1997 Q2 | 40.9 Million USD | 87.61% |
| 1997 FY | 106.7 Million USD | 5715.79% |
| 1997 Q4 | 106.7 Million USD | 40.77% |
| 1997 Q1 | 21.8 Million USD | 1247.37% |
| 1997 Q3 | 75.8 Million USD | 85.33% |
| 1996 Q4 | -1.9 Million USD | 81.37% |
| 1996 Q1 | 48.1 Million USD | 35.49% |
| 1996 Q2 | -56.2 Million USD | -216.84% |
| 1996 Q3 | -10.2 Million USD | 81.85% |
| 1996 FY | -1.9 Million USD | -105.35% |
| 1995 Q4 | 35.5 Million USD | 0.0% |
| 1995 FY | 35.5 Million USD | -37.28% |
| 1994 FY | 56.6 Million USD | 0.0% |
| 1994 Q4 | 56.6 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Phreesia, Inc. | -75.53 Million USD | 3502.306% |
| Accuray Incorporated | 103.58 Million USD | -2381.03% |
| Align Technology, Inc. | -840.47 Million USD | 405.781% |
| Elevance Health Inc. | 18.59 Billion USD | 86.178% |
| AxoGen, Inc. | 32.26 Million USD | -7865.041% |
| Boston Scientific Corporation | 8.23 Billion USD | 68.78% |
| CVS Health Corporation | 71.18 Billion USD | 96.39% |
| Cardinal Health, Inc. | 476 Million USD | -439.916% |
| Centene Corporation | 506 Million USD | -407.905% |
| DaVita Inc. | 10.65 Billion USD | 75.873% |
| HCA Healthcare, Inc. | 40.92 Billion USD | 93.72% |
| Hologic, Inc. | 374.4 Million USD | -586.432% |
| Humana Inc. | 5.51 Billion USD | 53.434% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -420.298% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | 52.56% |
| Masimo Corporation | 804 Million USD | -219.652% |
| McKesson Corporation | 889 Million USD | -189.089% |
| Patterson Companies, Inc. | 648.47 Million USD | -296.313% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | 45.121% |
| ResMed Inc. | 635.57 Million USD | -304.359% |
| Teladoc Health, Inc. | 468.6 Million USD | -448.44% |
| Universal Health Services, Inc. | 5.24 Billion USD | 51.021% |
| Veeva Systems Inc. | -647.71 Million USD | 496.781% |
| Baxter International Inc. | 11.16 Billion USD | 76.984% |
| Becton, Dickinson and Company | 14.46 Billion USD | 82.231% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 196.606% |
| Danaher Corporation | 13.49 Billion USD | 80.952% |
| Stryker Corporation | 10.02 Billion USD | 74.362% |
| Medtronic plc | 23.67 Billion USD | 89.147% |